NuVasive to Participate in Upcoming Investor Conferences
NuVasive, Inc. (NASDAQ: NUVA), a leader in spine technology innovation, announced its participation in two upcoming investor conferences. On September 7, 2022, at the Wells Fargo Healthcare Conference in Boston, CFO Matt Harbaugh will present at 3:10 p.m. ET. Following that, on September 12, 2022, CEO Chris Barry and CFO Matt Harbaugh will speak at the Morgan Stanley 20th Annual Global Healthcare Conference in New York at 11:40 a.m. ET. Webcasts of the presentations will be available on their website for 30 days post-event.
- None.
- None.
SAN DIEGO, Aug. 23, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor conferences:
- 2022 Wells Fargo Healthcare Conference, September 7, 2022, Boston. Chief Financial Officer Matt Harbaugh will be speaking at 3:10 p.m. ET.
- Morgan Stanley 20th Annual Global Healthcare Conference, September 12, 2022, New York. Chief Executive Officer Chris Barry and Chief Financial Officer Matt Harbaugh will be speaking at 11:40 a.m. ET.
A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. After the live webcast, a replay of the presentations will remain available on the website for 30 days.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-upcoming-investor-conferences-301610512.html
SOURCE NuVasive, Inc.
FAQ
What conferences will NuVasive participate in September 2022?
Who will represent NuVasive at the Wells Fargo Healthcare Conference?
What time will NuVasive's presentations occur at the conferences?
Where can I watch the NuVasive conference presentations?
What is the stock symbol for NuVasive?
